The FDA ( U.S. Food and Drug Administration ) has approved Tabrecta ( Capmatinib ) for the treatment of adult patients with non-small cell lung cancer ( NSCLC ) that has spread to other parts of the b ...

The FDA ( U.S. Food and Drug Administration ) has approved Qinlock ( Ripretinib ) tablets as the first new drug specifically approved as a fourth-line treatment for advanced gastrointestinal stromal t ...

Imfinzi ( Durvalumab ) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer ( ES-SCLC ) in combination with standard-of-care ( SoC ) chem ...

The European Commission ( EC ) has granted marketing authorisation for the expanded use of Erleada ( Apalutamide ) to include the treatment of adult men with metastatic hormone-sensitive prostate canc ...

The FDA ( U.S. Food and Drug Administration ) has approved Xcopri ( Cenobamate tablets ) to treat partial-onset seizures in adults.
A seizure is a usually short episode of abnormal electrical activ ...